Correlation Between Janux Therapeutics and AbbVie

Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Janux Therapeutics and AbbVie Inc, you can compare the effects of market volatilities on Janux Therapeutics and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and AbbVie.

Diversification Opportunities for Janux Therapeutics and AbbVie

-0.62

Correlation Coefficient

Janux Therapeutics  AbbVie

Excellent diversification

The 3 months correlation between Janux and AbbVie is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and AbbVie go up and down completely randomly.

Pair Corralation between Janux Therapeutics and AbbVie

Given the investment horizon of 90 days Janux Therapeutics is expected to generate 10.63 times more return on investment than AbbVie. However, Janux Therapeutics is 10.63 times more volatile than AbbVie Inc. It trades about 0.05 of its potential returns per unit of risk. AbbVie Inc is currently generating about 0.04 per unit of risk. If you would invest  1,826  in Janux Therapeutics on February 26, 2024 and sell it today you would earn a total of  2,711  from holding Janux Therapeutics or generate 148.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Janux Therapeutics  vs.  AbbVie Inc

Janux Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Janux Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Janux Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

AbbVie Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental drivers remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Janux Therapeutics and AbbVie

The main advantage of trading using opposite Janux Therapeutics and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.

The idea behind Janux Therapeutics and AbbVie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.